This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Naomichi Matsumoto | |
|---|---|
| Name | Naomichi Matsumoto |
| Birth date | 1960s |
| Birth place | Osaka, Japan |
| Nationality | Japanese |
| Fields | Human genetics, Genomics, Cytogenetics |
| Workplaces | Nagoya University, Keio University, Baylor College of Medicine, Yokohama City University |
| Alma mater | Kyoto University, Nagoya University |
| Known for | Clinical cytogenetics, constitutional and acquired chromosomal abnormalities, genomic diagnostics |
Naomichi Matsumoto is a Japanese medical geneticist and clinical cytogeneticist recognized for contributions to chromosomal analysis, genomic diagnostics, and the characterization of rare congenital syndromes. He has held faculty and clinical positions at institutions including Nagoya University, Keio University, Yokohama City University, and international collaborations with Baylor College of Medicine and overseas consortia. Matsumoto's work bridges cytogenetics, molecular genetics, and translational medicine, influencing diagnostic strategies for congenital anomalies, intellectual disability, and hematologic malignancies.
Matsumoto was born in Osaka and completed preclinical and clinical training in Japan, receiving medical and doctoral degrees from Kyoto University and advanced training at Nagoya University School of Medicine. He trained in clinical cytogenetics and medical genetics in programs affiliated with Keio University School of Medicine and participated in collaborative fellowships with research groups at Baylor College of Medicine and international centers in Europe and North America. His formative mentors included faculty active in chromosomal research associated with institutions like Osaka University and Tokyo University Hospital.
Matsumoto served on staff at Nagoya University and later held professorial appointments at Keio University and Yokohama City University Graduate School of Medicine, directing clinical genetics services and cytogenetics laboratories. He established diagnostic pipelines integrating karyotyping, fluorescence in situ hybridization techniques developed at centers such as National Institutes of Health collaborations, and chromosomal microarray approaches paralleling efforts at Wellcome Trust Sanger Institute and Broad Institute. Matsumoto has collaborated with consortia including the Human Genome Organisation, patient advocacy groups and referral centers in Japan and internationally, contributing to guideline development akin to documents from American College of Medical Genetics and Genomics and laboratory networks at European Society of Human Genetics meetings.
Matsumoto advanced characterization of constitutional chromosomal rearrangements and pathogenic copy-number variants through combined cytogenetic and molecular approaches, paralleling discoveries from groups at Cambridge University and Harvard Medical School. He reported genotype–phenotype correlations for rare syndromes, collaborating with clinical sites such as Children's Hospital of Philadelphia and geneticists from Saitama Medical University and Hokkaido University. His laboratory implemented genomic diagnostics for intellectual disability, developmental delay, and congenital anomalies, integrating algorithms similar to pipelines at Riken and Center for Genomic Medicine, Kyoto University. Matsumoto contributed to studies distinguishing clonal chromosomal changes in hematologic disorders, cooperating with hematology groups at Kyoto Prefectural University of Medicine and translational teams at Fred Hutchinson Cancer Research Center. He participated in delineation of novel microdeletion and duplication syndromes, reporting breakpoints and mechanism hypotheses consistent with nonallelic homologous recombination models discussed by researchers at Max Planck Institute for Molecular Genetics and Cold Spring Harbor Laboratory.
Matsumoto has received recognition from Japanese and international organizations, including honors from professional societies analogous to awards given by Japanese Society of Human Genetics and lectureships at meetings hosted by American Society of Human Genetics and European Society of Human Genetics. He has been invited to present at symposia organized by institutions such as Keio University, Nagoya University, Kyoto University, and international conferences at venues like Cold Spring Harbor Laboratory and Wellcome Trust Genome Campus.
Matsumoto's selected works include peer-reviewed articles on constitutional chromosomal abnormalities, chromosomal microarray diagnostics, and cytogenetic characterization of leukemia-related rearrangements published in journals and proceedings associated with Nature Publishing Group, Oxford University Press, and society journals of American Society of Human Genetics and European Society of Human Genetics. He coauthored reviews and guideline-like statements on clinical cytogenetic practice comparable to recommendations from American College of Medical Genetics and Genomics and collaborative case series with authors from Baylor College of Medicine, Children's Hospital of Philadelphia, and Riken.
Outside academia, Matsumoto has engaged with patient advocacy organizations and public genomic education initiatives in partnership with groups like Japan Intractable Diseases Information Center and national outreach programs similar to events hosted by Ministry of Health, Labour and Welfare (Japan). He has participated in interdisciplinary workshops with ethicists and clinicians from University of Tokyo and international stakeholders to address counseling and return-of-results policies reflecting debates at National Human Genome Research Institute and World Health Organization forums.
Category:Japanese geneticists Category:Medical geneticists Category:Living people